Misplaced Pages

MEDA

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article is about the psychedelic drug. For the instrument on the Perseverance rover, see Mars Environmental Dynamics Analyzer.
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.
Find sources: "MEDA" – news · newspapers · books · scholar · JSTOR (July 2019)
MEDA
Names
Preferred IUPAC name 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
KEGG
PubChem CID
UNII
InChI
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3Key: NRVFDGZJTPCULU-UHFFFAOYSA-N
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
SMILES
  • NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
Properties
Chemical formula C12H17NO3
Molar mass 223.272 g·mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). ☒N verify (what is  ?) Infobox references
Chemical compound

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

See also

References

  1. MEDA entry in PiHKAL


Stub icon

This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: